Correction to: The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management

• Published in: The American journal of gastroenterology Vol. 116; no. 2; pp. 435 - 439
• Main Authors: Omidvari, Amir-Houshang, Roumans, Carlijn A.M., Naber, Steffie K., Kroep, Sonja, Wijnhoven, Bas P.L., van der Gaast, Ate, de Jonge, Pieter-Jan, Spaander, Manon C.W., Lansdorp-Vogelaar, Iris
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer 01.02.2021; Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
• ISSN: 0002-9270; 1572-0241
• DOI: 10.14309/ajg.0000000000001027

See PDF] Sensitivity analyses Our results were robust for assumptions regarding the age of the simulated BE cohort, progression rate to BE, and lower participation rates of patients for surveillance or EET with similar increases in costs and QALYs, as in the main analysis, and incremental costs per QALY gained were around or above €35,000 for all strategies (Table 4 and see Appendix Table 4, Supplementary Digital Content 6, http://links.lww.com/AJG/B457). [...]the policy-practice gap in BE management is probably larger because of low adherence of clinicians to the biopsy protocol, which can result in a lower detection rate of dysplasia (41). [...]the beneficial effect of intensified surveillance may be even lower than what we have estimated. [...]our findings indicate that the policy-practice gap in BE surveillance intervals results in more than 100% higher costs for only up to 14% more QALYs gained.